The application of personalized medicine depends heavily on the availability of rigorous diagnostic tools that allow the optimal selection of therapeutic products to improve patient outcomes. According to the Food and Drug Administration (FDA), personalized medicine aims to provide benefits that reduce patient risks by targeting prevention and treatment more effectively. The field of personalized medicine predicts the human response to medicines and diseases based on intraspecific differences. Researchers help in developing approaches to personalized medicines for many genetic disorders. These personalized medicines use custom genetic interventions such as antisense-mediated exon skipping or genome editing to restore protein function in a mutation-specific manner. In drug discovery and development, mice models have played an essential role by characterizing disease pathophysiology and associated injury mechanisms; identifying drug targets; and evaluating novel therapeutics for toxicity/safety, pharmacokinetics, pharmacodynamics, and efficacy. Animal models can facilitate the development of personalized medicine approaches. Personalized medicine approaches need to be developed and preclinically tested in relevant cell and mouse models that ideally contain the human target sequences. The animal models used for personalized medicine research and drug discovery & development are provided with specific diets so that the animal model will react according to the human environment. Therefore, with the rising demand for personalized medicines, the laboratory animal diet market is growing substantially across Europe.
Market Overview
The Europe laboratory animal diets market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The market growth is attributed to the growing demand for animal models to study nutrition-related problems. Additionally, the rising production of animal models by pharmaceutical companies to study treatment for rare diseases such as osteoarthritis and cardiomyopathy is likely to create opportunities for the market players in the coming years. In Germany, pigs are the most used animal models for the clinical validation of drugs and medical devices. Their similarity to humans in terms of physiology, genetics, and anatomy is driving the demand for pig models. For instance, in 2020, the German Centre for Diabetes Research used pig models to examine organ crosstalk and complications in diabetes mellitus. In addition, a rise in the application of pigs as animal models in research activity is contributing to the market growth. Thus, the increasing use of animals for experimental purposes is contributing to the growth of the laboratory animal diet market.
The Europe laboratory animal diets market is segmented into diet type, animal, application, end user, and country.
Based on diet type, the market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment registered the largest market share in 2022.
Based on animal, the Europe laboratory animal diets market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment registered the largest market share in 2022.
Based on application, the Europe laboratory animal diets market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment registered the largest market share in 2022.
Based on end user, the Europe laboratory animal diets market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment registered the largest market share in 2022.
Based on country, the Europe laboratory animal diets market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
Altromin Spezialfutter GmbH & Co. KG, Bio-Serv, Envigo, Krishna Valley Agrotech LLP, LabDiet, Research Diets Inc., SAFE, Special Diet Services, and Specialty Feeds are the leading companies operating in the laboratory animal diets market in Europe.
Strategic insights for the Europe Laboratory Animal Diets provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 1,390.14 Million |
Market Size by 2028 | US$ 1,882.51 Million |
Global CAGR (2022 - 2028) | 5.3% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Diet Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Laboratory Animal Diets refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Europe Laboratory Animal Diets Market is valued at US$ 1,390.14 Million in 2022, it is projected to reach US$ 1,882.51 Million by 2028.
As per our report Europe Laboratory Animal Diets Market, the market size is valued at US$ 1,390.14 Million in 2022, projecting it to reach US$ 1,882.51 Million by 2028. This translates to a CAGR of approximately 5.3% during the forecast period.
The Europe Laboratory Animal Diets Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Laboratory Animal Diets Market report:
The Europe Laboratory Animal Diets Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Laboratory Animal Diets Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Laboratory Animal Diets Market value chain can benefit from the information contained in a comprehensive market report.